She's turning machine learning into a drug discovery engine

Daphne Koller, the former ed-tech entrepreneur who jumped to anti-aging drug research company Calico, is launching a company turning machine learning on drug discovery and development. Not much is known at this point about Insitro, but it has won the backing of prominent biotech venture capital firms at the intersection of tech and biotech, including Foresite Capital, Alphabet investment arm GV, Third Rock Ventures, Andreessen Horowitz and ARCH Ventures. The company's website s ays it will apply…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news